COVID-19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care system.
Chen FuJames H StoeckleLena MasriAbhishek PandeyMeng CaoDalia LittmanMarissa RybsteinSunil E SaithKinan YartaAbhinav RohatgiDanil V MakarovScott E ShermanChristy D MorrisseyAlexander C JordanBeatrice RazzoPoy TheprungsirikulJoseph TsaiDaniel J BeckerPublished in: Cancer (2021)
Our investigators found that hospitalized patients with active cancer were more likely to die from coronavirus disease 2019 (COVID-19) than those with a history of cancer and those without any cancer history. Patients with hematologic cancers were the most likely among patients with cancer to die from COVID-19. Patients who received cancer therapy within 3 months before hospitalization did not have an increased risk of death.